Showing results (241-250 of 262) with videos related to
Sort By:
Pageof 27
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.Cell|May 21, 2021
Charting human development using a multi-endodermal organ atlas and organoid modelsQianhui Yu, Umut Kilik, Emily M Holloway, et al.Inflammatory Bowel Diseases|December 6, 2021
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVIDKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.Gut|May 19, 2012
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialWolfgang Hueber, Bruce E Sands, Steve Lewitzky, et al.Inflammatory Bowel Diseases|January 24, 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.Nature Medicine|February 19, 2020
Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiotaHiroko Nagao-Kitamoto, Jhansi L Leslie, Sho Kitamoto, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2024
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and EndpointsSailish Honap, Vipul Jairath, Bruce E Sands, et al.Gastroenterology|April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal SurgeryBenjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.Lancet (London, England)|June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trialsSilvio Danese, Séverine Vermeire, Wen Zhou, et al.The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.Pageof 27